Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Certain hormone treatments can improve acne and related conditions in women.

Menopause affects hair and skin; more research needed for treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Many women with hard-to-treat acne also have PCOS.

Hair loss in postmenopausal woman caused by ovarian issue.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.